Brief ischemia-reperfusion induces stunning of endothelium in canine coronary artery

Circulation

Volumn 85, Issue 4, 1992, Pages 1473-1482

  Kim, Young D ^a,b   Fomsgaard, Jonna S ^a   Heim, Kurt F ^a   Ramwell, Peter W ^a   Thomas, George ^a   Kagan, Elliott ^a   Moore, Stephen P ^a   Coughlin, Steven S ^a   Kuwahara, Maki ^a   Analouei, Ali ^a   Myers, Adam K ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Endothelium derived relaxing factor; Myocardial ischemia; Vascular smooth muscle; Vasodilators

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; BRADYKININ; ENDOTHELIUM DERIVED RELAXING FACTOR; NITROPRUSSIDE SODIUM; POTASSIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; CORONARY ARTERY; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION; VASOMOTOR REFLEX;

ACETYLCHOLINE; ANIMAL; BRADYKININ; CORONARY VESSELS; DOGS; ENDOTHELIUM, VASCULAR; FEMALE; MALE; MICROSCOPY, ELECTRON; MYOCARDIAL REPERFUSION INJURY; NITROPRUSSIDE; POTASSIUM CHLORIDE; PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; VASOMOTOR SYSTEM;

EID: 0026608336     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.85.4.1473     Document Type: Article

References (58)

1. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376
2. Furchgott RF: Role of endothelium in responses of vascular smooth muscle. Circ Res 1983;53:557-573
3. Vanhoutte PM: The endothelium: Modulator of vascular smooth-muscle tone. N Engl J Med 1988;319:512-513
4. Lamping KG, Marcus ML, Dole WP: Removal of the endothelium potentiates canine large coronary artery constrictor responses to 5-hydroxytryptamine in vivo. Circ Res 1985;57:46-54
5. Cohen RA, Shepherd JT, Vanhoutte PM: 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries. Am J Physiol 1983;245:H1077-H1080
6. Ku DD: Coronary vascular reactivity after acute myocardial ischemia. Science 1982;218:576-578
7. Roberts WC, Curry RC Jr, Isner JM, Waller BF, McManus BM, Mariani-Constantini R, Ross AM: Sudden death in Prinzmetal's angina with coronary spasm documented by angiography: Analysis of three necropsy patients. Am J Cardiol 1982;50:203-210
8. Chierchia S, Davies G, Berkenboom G, Crea F, Crean P, Maseri A: α-Adrenergic receptors and coronary spasm: An elusive link. Circulation 1984;69:8-14
9. Hillis LD, Braunwald E: Coronary artery spasm. N Engl J Med 1978;299:695-702
10. Koiwaya Y, Torii S, Takeshita A, Nakagaki O, Nakamura M: Postinfarction angina caused by coronary arterial spasm. Circulation 1982;65:275-280
11. Nakamura M, Koiwaya Y: Effect of diltiazem on recurrent spontaneous angina after acute myocardial infarction. Circ Res 1983; 52(suppl I):I-158-I-162
12. Epstein SE, Quyyumi AA, Bonow RO: Myocardial ischemia: Silent or symptomatic. N Engl J Med 1988;318:1038-1043
13. Blumgart HL, Gilligan DR, Schlesinger MJ: Experimental studies on the effect of temporary occlusion of coronary arteries: II. The production of myocardial infarction. Am Heart J 1941;22:374-389
14. Braunwald E, Kloner RA: The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation 1982;66: 1146-1149
15. Ellis SG, Henschke CI, Sandor T, Wynn J, Braunwald E, Kloner RA: Time course of functional and biochemical recovery of myocardium salvaged by reperfusion. J Am Coll Cardiol 1983;1: 1047-1055
16. Hirzel HO, Leutwyler R, Krayenbuehl HP: Silent myocardial ischemia: Hemodynamic changes during dynamic exercise in patients with proven coronary artery disease despite absence of angina pectoris. J Am Coll Cardiol 1985;6:275-284
17. Virmani R, Forman MB, Kolodgie FD: Myocardial reperfusion injury: Histopathological effects of perfluorochemical. Circulation 1990;81(suppl IV):IV-57-IV-68
18. VanBenthuysen KM, McMurtry IF, Horwitz LD: Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest 1987;79:265-274
19. Braunwald E, Rutherford JD: Reversible ischemic left ventricular dysfunction: Evidence for the "hibernating myocardium." J Am Coll Cardiol 1986;8:1467-1470
20. Hale SL, Alker KJ, Kloner RA: Evaluation of nonradioactive, colored microspheres for measurement of regional myocardial blood flow in dogs. Circulation 1988;78:428-434
21. Dauber IM, VanBenthuysen KM, McMurtry IF, Wheeler GS, Lesnefsky EJ, Horwitz LD, Weil JV: Functional coronary microvascular injury evident as increased permeability due to brief ischemia and reperfusion. Circ Res 1990;66:986-998
22. Theroux P, Franklin D, Ross J Jr, Kemper WS: Regional myocardial function during acute coronary artery occlusion and its modification by pharmacologic agents in the dog. Circ Res 1974;35: 896-908
23. Sunnergren KP, Rovetto MJ: Myocyte and endothelial injury with ischemia reperfusion in isolated rat hearts. Am J Physiol 1987;252: H1211-H1217
24. Zar JH: Biostatistical Analysis, ed 2. Englewood Cliffs, NJ, Prentice Hall, 1984
25. Griffith TM, Edwards DH, Collins P, Lewis MJ, Henderson AH: Endothelium derived relaxant factor. J R Coll Physicians Lond 1985;19:74-79
26. Vanhoutte PM, DeMey J: Control of vascular smooth muscle function by the endothelial cells. Gen Pharmacol 1983;14:39-41
27. Ignarro LJ: Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989;65:1-21
28. Kloner RA, Ganote CE, Jennings RB: The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-1508
29. Braunwald E, Kloner RA: Myocardial reperfusion: A double-edged sword? J Clin Invest 1985;76:1713-1719
30. Armiger LC, Gavin JB: Changes in the microvasculature of ischemic and infarcted myocardium. Lab Invest 1975;33:51-56
31. Engler RL, Dahlgren MD, Peterson MA, Dobbs A, Schmid-Schönbein GW: Accumulation of polymorphonuclear leukocytes during 3-h experimental myocardial ischemia. Am J Physiol 1986; 251:H93-H100
32. Reynolds JM, McDonagh PF: Early in reperfusion, leukocytes alter perfused coronary capillarity and vascular resistance. Am J Physiol 1989;256:H982-H989
33. Crystal GJ, Downey HF, Bashour FA: Pressure-induced changes in coronary flow and volume during reperfusion in canine hearts. Clin Exp Pharmacol Physiol 1982;9:485-494
34. Grayson J, Irvine M, Parratt JR, Cunningham J: Vasospastic elements in myocardial infarction following coronary occlusion in the dog. Cardiovasc Res 1968;2:54-62
35. Guyton RA, McClenathan JH, Michaelis LL: Evolution of regional ischemia distal to a proximal coronary stenosis: Self-propagation of ischemia. Am J Cardiol 1977;40:381-392
36. Bertrand ME, LaBlanche JM, Tilmant PY, Thieuleux FA, Delforge MR, Carre AG, Asseman P, Berzin B, Libersa C, Laurent JM: Frequency of provoked coronary arterial spasm in 1,089 consecutive patients undergoing coronary arteriography. Circulation 1982;65:1299-1306
37. Kloner RA, Rude RE, Carlson N, Maroko PR, DeBoer LWV, Braunwald E: Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: Which comes first? Circulation 1980;62:945-952
38. Tilton RG, Larson KB, Udell JR, Sobel BE, Williamson JR: External detection of early microvascular dysfunction after no-flow ischemia followed by reperfusion in isolated rabbit hearts. Circ Res 1983;52:210-225
39. Forman MB, Puett DW, Bingham SE, Virmani R, Tantengco MV, Light RT, Bajaj A, Price R, Friesinger G: Preservation of endothelial cell structure and function by intracoronary perfluorochemical in a canine preparation of reperfusion. Circulation 1987;76: 469-479
40. Mehta JL, Nichols WW, Donnelly WH, Lawson DL, Thompson L, ter Riet M, Saldeen TGP: Protection by superoxide dismutase from myocardial dysfunction and attenuation of vasodilator reserve after coronary occlusion and reperfusion in dog. Circ Res 1989;65:1283-1295
41. Nicklas JM, Gips SJ: Decreased coronary flow reserve after transient myocardial ischemia in dogs. J Am Coll Cardiol 1989;13: 195-199
42. Forman MB, Virmani R, Puett DW: Mechanisms and therapy of myocardial reperfusion injury. Circulation 1990;81(suppl IV): IV-69-IV-78
43. Heyndrickx GR, Baig H, Nellens P, Leusen I, Fishbein MC, Vatner SF: Depression of regional blood flow and wall thickening after brief coronary occlusions. Am J Physiol 1978;234:H653-H659
44. Warltier DC, Al-Wathiqui MH, Kampine JP, Schmeling WT. Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. Anesthesiology 1988;69:552-565
45. Ambrosio G, Weisman HF, Becker LC: The "no-reflow" phenomenon: A misnomer? (abstract) Circulation 1986;74(suppl II):II-260
46. Hellstrom HR: Myocardial reperfusion injury: An assessment by the spasm of resistance vessel concept of ischemic heart disease. Med Hypotheses 1990;33:117-124
47. Jennings RB, Schaper J, Hill ML, Steenbergen C Jr, Reimer KA: Effect of reperfusion late in the phase of reversible ischemic injury: Changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ Res 1985;56:262-278
48. Ignarro LJ, Byrns RE, Buga GM, Wood KS: Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP. Am J Physiol 1987;253:H1074-H1082
49. Vanhoutte PM, Miller VM: Heterogeneity of endothelium-dependent responses in mammalian blood vessels. J Cardiovasc Pharmacol 1985;7(suppl 3):S12-S23
50. Gryglewski RJ, Moncada S, Palmer RMJ: Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells. Br J Pharmacol 1986;87:685-694
51. Lane GE, Bove AA: The effect of cyclooxygenase inhibition on vasomotion of proximal coronary arteries with endothelial damage. Circulation 1985;72:389-396
52. Gauduel Y, Duvelleroy MA: Role of oxygen radicals in cardiac injury due to reoxygenation. J Mol Cell Cardiol 1984;16:459-470
53. McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-163
54. Gryglewski RJ, Palmer RMJ, Moncada S: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454-456
55. Rubanyi GM, Vanhoutte PM: Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986; 250:H822-H827
56. Vanhoutte PM, Katusic ZS: Endothelium-derived contracting factor: Endothelin and/or superoxide anion? Trends Pharmacol Sci 1988;9:229-230
57. Hickey KA, Rubanyi G, Paul RJ, Highsmith RF: Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am J Physiol 1985;248:C550-C556
58. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415